Annual Accounts Receivable:
N/ASummary
- SMMT annual accounts receivable is not available.
Performance
SMMT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Quarterly Accounts Receivable:
N/ASummary
- SMMT quarterly accounts receivable is not available.
Performance
SMMT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
SMMT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | - | - |
| 3Y3 Years | - | - |
| 5Y5 Years | - | - |
SMMT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | ||||
| 5Y | 5-Year | ||||
| All-Time | All-Time |
SMMT Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) |
| Dec 2022 | $349.00K(-76.2%) | $349.00K(+149.3%) |
| Sep 2022 | - | $140.00K(-41.2%) |
| Jun 2022 | - | $238.00K(-72.6%) |
| Mar 2022 | - | $870.00K(-40.6%) |
| Dec 2021 | $1.46M(+342.3%) | $1.46M(-36.1%) |
| Sep 2021 | - | $2.29M(+117.5%) |
| Jun 2021 | - | $1.05M(+135.6%) |
| Mar 2021 | - | $447.00K(+35.0%) |
| Dec 2020 | $331.00K(-39.1%) | - |
| Dec 2020 | - | $331.00K(-91.9%) |
| Sep 2020 | - | $4.08M(-66.4%) |
| Mar 2020 | - | $12.13M(+456.7%) |
| Dec 2019 | $543.10K(>+9900.0%) | - |
| Jan 2019 | - | $2.18M(-88.3%) |
| Apr 2018 | - | $18.58M(>+9900.0%) |
| Jan 2018 | $0.00(0.0%) | - |
| Jan 2018 | - | $0.00(-100.0%) |
| Apr 2015 | - | $2.96M(+38.0%) |
| Oct 2014 | - | $2.14M(-1.7%) |
| Jul 2014 | - | $2.18M(+438.0%) |
| Jan 2014 | $0.00 | - |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2013 | - | $405.40K(+403.0%) |
| Jan 2013 | $80.90K(+9.0%) | - |
| Jan 2013 | - | $80.60K(-70.7%) |
| Jul 2012 | - | $274.90K(+272.5%) |
| Jan 2012 | $74.20K(+44.6%) | - |
| Jan 2012 | - | $73.80K(-90.8%) |
| Jul 2011 | - | $805.80K(+1492.5%) |
| Jan 2011 | $51.30K(-21.9%) | - |
| Jan 2011 | - | $50.60K(-80.7%) |
| Jul 2010 | - | $262.20K(+300.3%) |
| Jan 2010 | $65.70K(-93.0%) | - |
| Jan 2010 | - | $65.50K(-87.6%) |
| Jul 2009 | - | $529.60K(-43.6%) |
| Jan 2009 | $938.50K(+149.8%) | - |
| Jan 2009 | - | $938.30K(-63.9%) |
| Jul 2008 | - | $2.60M(+592.3%) |
| Jan 2008 | $375.70K(-32.2%) | - |
| Jan 2008 | - | $375.80K(-90.0%) |
| Jul 2007 | - | $3.76M(+576.7%) |
| Jan 2007 | $553.90K(+141.9%) | - |
| Jan 2007 | - | $555.10K(+141.0%) |
| Jan 2006 | $229.00K(+206.1%) | - |
| Jan 2006 | - | $230.30K(-69.5%) |
| Jul 2005 | - | $754.40K(+901.9%) |
| Jan 2005 | $74.80K | - |
| Jan 2005 | - | $75.30K |
FAQ
- What is the all-time high annual accounts receivable for Summit Therapeutics Inc.?
- What is the all-time high quarterly accounts receivable for Summit Therapeutics Inc.?
What is the all-time high annual accounts receivable for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high annual accounts receivable is $1.46M
What is the all-time high quarterly accounts receivable for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high quarterly accounts receivable is $18.58M